TB Alliance

TB Alliance TB Alliance is a non-profit product development partnership working to develop new, simpler, faster-acting TB drug treatments.

The TB Alliance is committed to supporting the development of Community Engagement (CE) strategies for clinical trials to serve as a bridge between trial researchers and local TB affected communities. Community Engagement strategies help to ensure that study participants, their families, community stakeholders, and others who may be affected by or at risk of TB infection, have an opportunity to pa

rtner with the scientific community in the implementation of research efforts. Community Engagement strategies can provide mechanisms for:

• educating communities about TB disease, treatment and the research process such as the different phases, the regulatory process, and in-built systems to ensure ethical conduct;
• obtaining community input into clinical trial implementation;
• understanding community perceptions and experiences, and identify community concerns so that they are addressed in the research process;
• liaising with community leaders to facilitate smooth implementation of clinical programs;
• sharing and discuss clinical trial and research results; and
• motivating communities to assist with policy and regimen change

We are thrilled to celebrate a milestone in the Fast Track the Cure initiative with our partner, Nari Maitree! This prog...
08/09/2025

We are thrilled to celebrate a milestone in the Fast Track the Cure initiative with our partner, Nari Maitree! This program is tailored to meet the needs of communities across Dhaka and Narayanganj and these partners will help drive awareness and accelerate access to life-saving treatments.

Fast Track the Cure

11/11/2024
At today’s High-Level Meeting hosted by the Indonesian Ministry of Health, we announced a new 1️⃣ X 1️⃣ approach to TB t...
11/11/2024

At today’s High-Level Meeting hosted by the Indonesian Ministry of Health, we announced a new 1️⃣ X 1️⃣ approach to TB treatment: The goal is to treat latent TB infections in one day and to treat active TB in one month. This strategy will help address the transformation of TB R&D and the accelerated rollout of TB drugs globally. Read more about it here:
https://www.tballiance.org/news/tb-alliance-joins-indonesia-high-level-meeting-tb

BALI, Indonesia (November 11, 2024)—TB Alliance is honored to join today’s High-Level Meeting hosted by the Indonesian Ministry of Health. Leaders and experts in tuberculosis (TB) have convened to discuss strategies, innovations, and achievements in the global fight to end TB. The full-day sessi...

By 2050,   is predicted to cause up to 10 million deaths annually if no effective interventions are made. Drug-resistant...
10/09/2024

By 2050, is predicted to cause up to 10 million deaths annually if no effective interventions are made. Drug-resistant is a significant contributor to the global burden of AMR. Today, at the Global AMR Summit in , Dr. Salah Foraida spoke on the intersection between and AMR and the need for global collaboration to improve treatment, surveillance, and prevention efforts.

We are proud to announce a four-year award through the U.S. Department of Defense within the Congressionally Directed Me...
10/07/2024

We are proud to announce a four-year award through the U.S. Department of Defense within the Congressionally Directed Medical Research Programs (CDMRP) for research and development exploring host-directed approaches for treating . Learn more about this work here: https://www.tballiance.org/news/tb-alliance-awarded-735-million-us-department-defense-novel-tuberculosis-interventions

New York (October 7, 2024) – TB Alliance is proud to announce a $7.35 million award through the U.S. Department of Defense. The four-year grant was received within the DOD’s Congressionally Directed Medical Research Programs (CDMRP) for research and development exploring host-directed approaches...

A world without   is possible. Together with global leaders, health organizations, and communities, we can achieve the g...
10/04/2024

A world without is possible. Together with global leaders, health organizations, and communities, we can achieve the goal to by 2030. We must work together to fight this age-old disease.

Drug-resistant   continues to challenge global health systems. By investing in innovative research and development, we c...
10/03/2024

Drug-resistant continues to challenge global health systems. By investing in innovative research and development, we can ensure no one is left behind.

The rise of drug-resistant   is a global health emergency. This week’s   High-Level Meeting on   was a crucial moment to...
09/27/2024

The rise of drug-resistant is a global health emergency. This week’s High-Level Meeting on was a crucial moment to push for bold action from world leaders to address TB as a key part of the fight against AMR.

  is one of the deadliest infectious diseases, and drug-resistant strains make the fight against   even more urgent. At ...
09/26/2024

is one of the deadliest infectious diseases, and drug-resistant strains make the fight against even more urgent. At today's AMR High-Level Meeting, we need global collaboration to tackle this crisis head-on.

Address

80 Pine Street
New York, NY
10005

Alerts

Be the first to know and let us send you an email when TB Alliance posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share